Showing results (101-110 of 151) with videos related to
Sort By:
Pageof 16
International Immunopharmacology|January 28, 2015
Conventional markers in determination of activity of sarcoidosisSinem Gungor, Ferhan Ozseker, Murat Yalcinsoy, et al.Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|July 22, 2016
Twenty-five years of the TARF study: The 2015 survey, and temporal trends in mortality and loss to follow-upAltan Onat, Adnan Kaya, Tuğba Akbaş Şimşek, et al.Atherosclerosis|August 24, 2006
Prospective epidemiologic evidence of a "protective" effect of smoking on metabolic syndrome and diabetes among Turkish women--without associated overall health benefitAltan Onat, Hakan Ozhan, A Metin Esen, et al.BMC Endocrine Disorders|September 30, 2016
Gender-modulated risk of coronary heart disease, diabetes and coronary mortality among Turks for three major risk factors, and residual adiposity riskGünay Can, Altan Onat, Eray Yurtseven, et al.World Journal of Diabetes|October 23, 2013
Impaired fasting glucose: Pro-diabetic, "atheroprotective" and modified by metabolic syndromeAltan Onat, Mesut Aydın, Günay Can, et al.Pediatrics International : Official Journal of the Japan Pediatric Society|November 26, 2011
Delivery room blood pressure percentiles of healthy, singleton, liveborn neonatesOzgül Salihoğlu, Emrah Can, Ayşegül Beşkardeş, et al.Journal of Pediatric Urology|November 9, 2021
Ureteral wall thickness at the stone site: A critical predictor of success and complications in children undergoing semi-rigid ureteroscopyElif Altınay Kırlı, Emre Bülbül, Onur Kaygısız, et al.Neurourology and Urodynamics|February 22, 2023
Voiding dynamics of pelvic organ prolapse: Large scale comparative studyBülent Çetinel, Elif A Kırlı, Bülent Önal, et al.The Turkish Journal of Gastroenterology : the Official Journal of Turkish Society of Gastroenterology|April 17, 2012
The effects of provocation by foods with raised IgG antibodies and additives on the course of Crohn's disease: a pilot studyHülya Uzunısmaıl, Mahir Cengız, Hafize Uzun, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|September 3, 2024
Hyperprogressive disease in patients with advanced cancer treated with immune checkpoint inhibitorsGülin Alkan Şen, Nihan Şentürk Öztaş, Ezgi Değerli, et al.Pageof 16